Literature DB >> 11097360

Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification.

G Bussolati1, M Bongiovanni, P Cassoni, A Sapino.   

Abstract

Modern classifications of ductal in situ carcinoma (DCIS) of the breast suffer from unsatisfactory reproducibility in inter-observer circulation analyses. Ducts in DCIS are markedly enlarged in the range of 360 microm in diameter. Since the diffusion of oxygen from peri-ductal vessels is limited to 100 microm, cells in the center of DCIS are poorly oxygenated and become either necrotic or remain hypoxic but viable. There is evidence that such alternative fate is dictated by the biological characteristics of the neoplastic cells. Therefore, determination of presence or absence of necrosis in ducts up to 360 microm in diameter might represent a simple, reproducible, and biologically sound criterion to classify DCIS. In the present work, following this criterion, we classified 32 cases of intra-ductal lesions as either "necrotic" or "hypoxic" and tested the reproducibility of such classification using K statistics. These cases had already been circulated among a group of European pathologists, who classified the lesions using five different classifications. The K statistics value obtained with the presently proposed system was extremely high (0.91). It remains to be established whether the classification "necrotic/hypoxic" withstands large inter-observer circulation analyses, whether it is predictive of the clinical evolution of DCIS, and whether it might constitute a reproducible basis for selecting appropriate treatments.

Entities:  

Mesh:

Year:  2000        PMID: 11097360     DOI: 10.1007/s004280000267

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  10 in total

Review 1.  What is the malignant nature of human ductal carcinoma in situ?

Authors:  Virginia Espina; Lance A Liotta
Journal:  Nat Rev Cancer       Date:  2010-12-02       Impact factor: 60.716

2.  Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ.

Authors:  Moacyr Jesus Barreto de Melo Rêgo; Gabriela Souto Vieira de Mello; Carlos André da Silva Santos; Roger Chammas; Eduardo Isidoro Carneiro Beltrão
Journal:  Med Mol Morphol       Date:  2013-02-05       Impact factor: 2.309

3.  A 2D mechanistic model of breast ductal carcinoma in situ (DCIS) morphology and progression.

Authors:  Kerri-Ann Norton; Michael Wininger; Gyan Bhanot; Shridar Ganesan; Nicola Barnard; Troy Shinbrot
Journal:  J Theor Biol       Date:  2009-12-16       Impact factor: 2.691

4.  Attacking breast cancer at the preinvasion stage by targeting autophagy.

Authors:  Virginia Espina; John Wysolmerski; Kirsten Edmiston; Lance A Liotta
Journal:  Womens Health (Lond)       Date:  2013-03

5.  Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models.

Authors:  Lu Jiang; Tiffany R Greenwood; Dmitri Artemov; Venu Raman; Paul T Winnard; Ron M A Heeren; Zaver M Bhujwalla; Kristine Glunde
Journal:  Neoplasia       Date:  2012-08       Impact factor: 5.715

6.  Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors.

Authors:  Liat Goldshaid; Efrat Rubinstein; Alexander Brandis; Dadi Segal; Noa Leshem; Ori Brenner; Vyacheslav Kalchenko; Doron Eren; Tamar Yecheskel; Yoseph Salitra; Yoram Salomon; Avigdor Scherz
Journal:  Breast Cancer Res       Date:  2010-05-24       Impact factor: 6.466

7.  Lattice-based model of ductal carcinoma in situ suggests rules for breast cancer progression to an invasive state.

Authors:  Eline Boghaert; Derek C Radisky; Celeste M Nelson
Journal:  PLoS Comput Biol       Date:  2014-12-04       Impact factor: 4.475

8.  Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis.

Authors:  Mayuko Chishiki; Kiyoshi Takagi; Ai Sato; Yasuhiro Miki; Yuta Yamamoto; Akiko Ebata; Yukiko Shibahara; Mika Watanabe; Takanori Ishida; Hironobu Sasano; Takashi Suzuki
Journal:  Cancer Sci       Date:  2017-05-19       Impact factor: 6.716

9.  Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent.

Authors:  Zoltan Szucs; James Joseph; Tim J Larkin; Bangwen Xie; Sarah E Bohndiek; Kevin M Brindle; André A Neves
Journal:  Breast Cancer Res       Date:  2021-02-17       Impact factor: 6.466

10.  HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.

Authors:  Petra van der Groep; Paul J van Diest; Yvonne H C M Smolders; Margreet G E M Ausems; Rob B van der Luijt; Fred H Menko; Joost Bart; Elisabeth G E de Vries; Elsken van der Wall
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.